Company Filing History:
Years Active: 2009
Title: Heidi Kidron: Innovator in Vascular Adhesion Protein Research
Introduction
Heidi Kidron is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of vascular adhesion proteins, particularly through her innovative research and patenting activities. Her work focuses on the structural information of crystalline human VAP-1, which has important implications for medical research and drug development.
Latest Patents
Heidi Kidron holds a patent for her invention titled "Crystalline VAP-1 and uses thereof." This patent relates to crystalline vascular adhesion protein-1 (VAP-1) and outlines methods for utilizing structural information of crystalline human VAP-1 for the identification, design, and production of ligands and inhibitors. The invention also includes screening assays for the detection of these compounds, as well as inhibitors identified through the assays.
Career Highlights
Heidi Kidron is associated with Biotie Therapies Corporation, where she has been instrumental in advancing research related to vascular adhesion proteins. Her expertise and innovative approach have positioned her as a key figure in her field.
Collaborations
Heidi collaborates with notable colleagues, including Tiina Annamaria Salminen and Tomi Airenne. Their combined efforts contribute to the ongoing research and development in the area of vascular adhesion proteins.
Conclusion
Heidi Kidron's work exemplifies the impact of innovation in the field of medical research. Her contributions through her patent and collaborations continue to advance the understanding and application of vascular adhesion proteins.